Regenerative & orthobiologic
Practices already working with biologics who want a source that stands up to scrutiny from a well-informed patient.
For Clinics
Your patients already ask about this. Answer them properly.
Regenerative medicine has a credibility problem, and it was earned. The market is full of material with no characterisation, no traceable source and no science behind the claims on the box. A clinic that wants to operate at a higher standard has had very little to choose from.
01 — Fit
Who the programme is built for
We are not trying to sign every clinic. Provider numbers are limited by territory, and the review is genuine — the wrong provider damages the brand for every other provider in the network.
Aesthetic & dermatology
Clinics whose patients are already spending at the top of the market and expect the science to justify the price.
Longevity & preventative
Programmes built around biological age, where the age of the material itself is the entire argument.
Hair restoration
Practices tracking the follicle and secretome research, positioned for the topical programme as it becomes available.
Sports & performance
Clinics serving athletes and demanding patients where provenance and documentation are non-negotiable.
Research-active practices
Groups running IRB-supervised protocols who need characterised, traceable, consistent material.
02 — The package
What arrives with every provider account
Material
Characterised biological material, cold-chain shipped, with full lot traceability from source to your door.
Documentation
Certificate of analysis, identity and viability data, sterility and pathogen screening results per lot.
Training
Structured onboarding on storage, handling, preparation and documentation — completed before first shipment.
Support
A named scientific liaison who knows the platform, reachable directly rather than through a queue.
Patient tools
Claim-controlled education materials written to inform a patient accurately, not to oversell to them.
Compliance
Source, manufacturing and classification documentation supplied up front for your regulatory review.
Territory
Provider density is capped by region. Standing is reviewed at application, and it is not first-come.
Provider clinic environment
03 — Process
From application to first shipment
Apply
A four-minute application covering your practice, licensure, specialty and intended use. Reviewed by a person.
Verification
We verify licensure and standing, and discuss the regulatory environment you operate in. Some applications are declined here.
Protocol training
Your clinical team completes handling and documentation training with the scientific liaison assigned to your account.
Activation
Territory is confirmed, your provider account opens, and the first shipment is scheduled.
04 — Straight talk
What we will not do
Every clinic reading this has been pitched by someone who promised more than they could support. So here is the boundary, stated before you apply rather than after.
We will not
- Tell you this material treats, cures or prevents any disease. It is not FDA-approved for that, and no one can honestly claim otherwise.
- Present preclinical animal data as though it were human clinical evidence.
- Advise you that a given use is lawful in your jurisdiction — that determination is yours, with your own counsel.
- Supply a clinic that intends to market it with claims we could not stand behind.
We will
- Give you the complete characterisation and manufacturing documentation, including what is not yet known.
- Tell you plainly where the science is preclinical and where it is more established.
- Put a named scientist in front of your clinicians, not a salesperson.
- Cap provider density so your territory position means something.
05 — Clinic FAQ
Before you apply
Pricing is confirmed at verification, because it depends on format, volume and territory. We do not publish a price list, and we do not quote before we know your practice is a fit — quoting first tends to produce the wrong conversation.
Provider density is capped by region rather than granted as blanket exclusivity. In practice this means a limited number of providers per territory, reviewed on standing rather than sold to whoever applies first. Specific territory terms are discussed at verification.
Requirements depend on the format supplied and are covered in full during protocol training before your first shipment. If your facility cannot meet the cold-chain requirement for a given format, we will say so during verification rather than ship and hope.
Research-active practices are among the applicants we most want to hear from. Indicate it on your application and we will route you to the scientific team directly. Appropriate ethical oversight for any research use is the investigating clinic's responsibility.
The serum programme is in development and not yet available for sale. Approved provider clinics are placed on the early-access list automatically and are notified before general availability. We will not commit to a date we cannot hold.
It is read by a person, usually within two business days. If your practice is a fit you will be contacted to schedule verification. If it is not, you will be told directly rather than left waiting.